Pharmaceutical compositions for inhibiting bone loss containing 3 and 4-substituted 2(5h)-furanones
CA 2133985 A1 · Owner: Garst, Michael E. · Inventors: Garst, Michael E.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
2133985 9321915 PCTABS00027, 3 and 4-substituted 2(5H)-furanone compounds influence the balance between bone production and bone resorption in mammals including humans. The active compounds are administered to mammals including humans, in an effective dose which ranges between 0.05 to 100 mg per kilogram, body weight, per day for the purpose of, influencing the balance between bone production and bone resorption and particularly for treating osteoporosis.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed April 21, 1993. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended April 21, 2013.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by April 21, 2015.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.